Uriah Bekenstein's profile

Uriah Bekenstein

CEO

Nucleo Technologies INC

I'm working on

2 years ago

Startup in drug-delivery: we bring therapeutics to the

About

NucleoTech is a biotechnology startup focusing on the delivery of Biologics and Oligo Drugs past the blood barrier, and into the brain. We are open for collaborative research; and our unique value proposition is synergistic with AI-protein design.

Partnering listings

Learn more

Nucleo Technologies INC

Ai-enhanced in-vivo screening assay for CNS drug delivery systems

Nucleo Technologies introduces a novel in-vivo screening assay that leverages AI tools to enhance the development of CNS drug delivery systems (DDSs). This approach integrates AI design, yeast surface display, and propri...

TechnologyIn developmentCompany

Uriah Bekenstein

CEO

Nucleo Technologies INC

Work experience

Nucleo Technologies INC

CEO

Top industry applications

Not enough data yet.
Results may appear later and can be imperfect.

Open to opportunities in

Not enough data yet.
Results may appear later and can be imperfect.

Last updated Jan 2025